“The Diabeter acquisition is a milestone for Medtronic and for the Diabetes Group,” said Hooman Hakami, executive vice president and president of the Diabetes Group at Medtronic. “This acquisition marks Medtronic’s first entry into a diabetes integrated care model approach and signifies that Medtronic Diabetes is more than pumps and sensors – we are a holistic diabetes management company focused on making a real difference in outcomes and cost.”
As one of the largest independent diabetes specialist centers for type 1 pediatrics and young adults in Europe, Diabeter currently manages over 1,500 patients and is recognized as a top center for diabetes care and clinical research. The team of 36 people at 4 locations practices personalized medicine making use of specially developed technologies, such as the Diabeter Dashboard, an electronic system that links patient and physician to encourage self-management with diabetes care team support. Internal Diabeter data shows that their patients have achieved significant reductions in HbA1c levels, a key measurement used to assess blood glucose control. Near normal blood glucose control has been show to reduce long-term complications of diabetes and can reduce healthcare costs over the long term.
“Diabeter has been pioneering this type of integrated care in the Netherlands, and we believe this approach can be applied more broadly to serve more patients, in more places around the world,” said Henk Veeze, M.D., Ph.D., senior international medical director, Diabeter. “We have developed a unique system with improved clinical outcomes, combining outstanding clinical care with devices and information technology.”
2nd April 2015 – Full Press Release
The company’s goal is to serve 20 million patients with diabetes by 2020, an approximate 20-fold increase from its current worldwide patient base of ~700,000. – See more at:
